MEDevice Boston 2026 Industry Report

MEDevice Boston 2026 ran August 26–27 at the Thomas M. Menino Convention & Exhibition Center (the venue formerly known as the BCEC) with more than 200 booths spanning 20-plus product solution categories, three conference tracks, four hands-on workshops and two keynotes. MIT's Paola Cappellaro opened day one on quantum sensing and the future of precision medicine; day two turned to designing AI-native devices for 2030. The Growth & Investment track put valuation squarely on the agenda, including a session titled "Mergers & Acquisitions in MedTech: Positioning for Strategic Growth." Read together, the program and the floor pointed at the same things acquirers are already paying for: validated quality systems in the first post-QMSR year, regulatory pathway discipline, advanced materials, and US and nearshore capacity against an unresolved tariff picture. Read our MEDevice Boston 2026 MedTech Industry Post-Show Report to learn more about where M&A for medical device design & manufacturing companies has been and where it is headed.

Questions? Click the button below to connect with our team.

Happy reading!